Quality of Life Enjoyment and Satisfaction Questionnaire

Endicott, Jean; Nee, John; Harrison, Wilma; Blumenthal, Richard

doi:10.1037/t49981-000

Cited by 982 publications

(1,211 citation statements)

References 15 publications

Supporting

Mentioning

1,170

Contrasting

Unclassified

Order By: Relevance

“…The postmorbid emotional scales of the RNBI were significantly correlated (P ¼ 0.01) with matching subscales of the Millon Clinical Multiaxial Inventory-III. 27 Similarly, significant correlations were demonstrated for the postmorbid QOL scales in comparisons with both the QOL enjoyment and satisfaction questionnaire 28 and the Mayo-Portland Adaptability Inventory. 29 Given that the RNBI is unique in capturing multiple functions before and after an illness, no published tests were available for validation of the premorbid scales.…”

Section: Outcome Measuresmentioning

confidence: 88%

Impact of spinal cord injury on self-perceived pre- and postmorbid cognitive, emotional and physical functioning

et al. 2007

View full text Add to dashboard Cite

Study Design: Cross-sectional study with repeated measurements. Objectives: To examine the patient's perspective of the impact of spinal cord injury (SCI) on physical, cognitive, emotional function, and quality of life (QOL). Setting: Australia. Methods: A sample of 63 patients with SCI, 32 of whom had recent injuries, and 31 with established injuries were administered the Ruff Neurobehavioral Inventory to examine patients' subjective evaluation of pre-and post-injury functioning. Current happiness levels were also evaluated using the Subjective Happiness Scale. A follow up assessment was performed 6 months later to examine changes over time. Results: A significant difference was found between perception of pre-and postmorbid function on composite Cognitive (t ¼ 5.99, df ¼ 62, Po0.001), Physical (t ¼ 11.56, df ¼ 62, Po0.001), and QOL (t ¼ 7.16, df ¼ 62, Po0.001) scales and on several of the Emotional subscales including anxiety, paranoia and suspicion, and substance abuse (Po0.001). A series of hierarchical regression analyses indicate that post-SCI pain was a significant predictor of: cognitive (R 2 ¼ 0.20, Po0.001); emotional (R 2 ¼ 0.13, Po0.004); and of QOL (R 2 ¼ 0.22, Po0.001) functioning. With the exception of a decrease in happiness (Po0.01), there were no significant changes in any measures over the 6 month time period. Conclusions: There are significant changes in patients' perceptions of physical and cognitive functioning, and of QOL before and after SCI and some aspects of emotional functioning. Pain has a significant adverse effect on functioning. Happiness decreased slightly in the 6 months between surveys.

show abstract

Section: Outcome Measuresmentioning

confidence: 88%

Impact of spinal cord injury on self-perceived pre- and postmorbid cognitive, emotional and physical functioning

et al. 2007

View full text Add to dashboard Cite

show abstract

“…The main outcome ratings used in the study were the MADRS (Montgomery and Asberg, 1979), the Hamilton Rating Scale for Depression (HAM-D) (Hamilton, 1960), the Clinical Global Impression of Severity (CGI-S) (Guy, 1976) and the overall functioning item of the Quality of Life and Enjoyment Questionnaire (Q-LES-Q) (Endicott et al, 1993). The MADRS was chosen a priori as the primary outcome measure because it is more sensitive to change than the HAM-D and more strongly reflects clinical judgment (Calabrese et al, 1999;Jahn et al, 2004;Mulder et al, 2003).…”

Section: Outcome Measuresmentioning

confidence: 99%

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

Keitner

Garlow

Ryan

et al. 2009

Journal of Psychiatric Research

View full text Add to dashboard Cite

Objective-Patients (30-50%) with non-psychotic major depression will not respond despite an adequate trial of antidepressant medication. This study evaluated risperidone as an augmenting agent for patients who failed or only partially responded to an adequate trial of an antidepressant medication.Method-Ninety-seven patients with unipolar non-psychotic major depression who were not responsive to antidepressant monotherapy were randomized to risperidone (0.5-3 mg/day) or placebo augmentation in a four-week, double-blind, placebo controlled treatment trial. The primary outcome measure was remission defined by a score of ≤10 on the Montgomery-Asberg Depression Rating Scale (MADRS). Secondary outcomes measures were the Hamilton Rating Scale for Depression, the Clinician Global Impression of Severity scale and the overall satisfaction item of the Quality of Life and Enjoyment Questionnaire.Results-Subjects in both treatment groups improved significantly over time. The odds of remitting were significantly better for patients in the risperidone vs. placebo arm (OR = 3.33, p = . 011). At the end of 4 weeks of treatment 52% of the risperidone augmentation group remitted (MADRS ≤ 10) compared to 24% of the placebo augmentation group (CMH(1) = 6.48, p = .011), but the two groups were converging. Patients in the risperidone group also reported significantly more improvement in quality-of-life than patients in the placebo group. There were no betweengroup differences in the number of adverse events reported, however, weight gain was significantly higher in the group receiving risperidone. Conclusion-Augmentation of an antidepressant with risperidone for patients with difficult-totreat depression leads to more rapid response and a higher remission rate and better quality-of-life.

show abstract

“…In particular, the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) (Endicott et al, 1993) has been used widely to measure life satisfaction in patients during pre and post treatment phases of therapy.…”

Section: Introductionmentioning

confidence: 99%

Quality of life of ‘normal’ controls: Association with lifetime history of mental illness

Schechter¹,

Endicott²,

Nee³

2007

Psychiatry Research

Self Cite

View full text Add to dashboard Cite

show abstract

Quality of Life Enjoyment and Satisfaction Questionnaire

Cited by 982 publications

References 15 publications

Impact of spinal cord injury on self-perceived pre- and postmorbid cognitive, emotional and physical functioning

Impact of spinal cord injury on self-perceived pre- and postmorbid cognitive, emotional and physical functioning

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

Quality of life of ‘normal’ controls: Association with lifetime history of mental illness

Contact Info

Product

Resources

About